Delivery Order SPE2DB24D9241-SPE2DB24FHGKS

Award Date 8/29/24
Potential Completion Date 9/20/24
Potential Value $2.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,576.28, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,564,598,902 units of the contraceptive implant Nexplanon 68 mg. The contract is a firm fixed-price delivery order with a period of performance through May 31, 2024. This award is part of a larger indefinite delivery contract (IDC) valued at up...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,858.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of 4,566,777,090 units of the contraceptive implant Nexplanon. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 Indefinite Delivery Contract (IDC) with the DLA, which enables the agency to procure a wide range of pharmaceutical products,...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $3,573.45, is for the supply of Nexplanon 68 mg implants, a type of contraceptive device. This award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. The...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $6,259.40 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The award is for the supply of 4,554,941 units of the contraceptive implant Nexplanon 68 mg. This order was issued under an Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which enables the agency to procure a wide range of pharmaceutical products,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for the provision of 4,565,306,259 units of the contraceptive implant NEXPLANON 68 MG. The award is part of a larger indefinite delivery contract (IDC) worth up to $499,999,999 under the DLA's SPE2DB program, which enables the agency to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,858.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 4,565,480 units of the contraceptive implant Nexplanon 68 mg. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) under the DLA's SPE2DB program, which allows the agency to issue delivery orders for a wide range of...
This federal contract award, valued at $4,102.44, was issued by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a firm fixed-price delivery order for the supply of 4,562,548,641 units of the contraceptive implant Nexplanon 68 mg. The award is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under the SPE2DB...
This contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $8,576.28 firm fixed-price delivery order is for 68 mg Nexplanon contraceptive implants. The order was placed under DMS Pharmaceutical Group's existing $499,999,999 indefinite delivery contract (IDC) with the DLA, which runs through December 31, 2025. This single-award IDC vehicle allows the DLA to issue...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,554.48 firm fixed-price delivery order is for the procurement of 4,566,924,663 units of the contraceptive implant NEXPLANON 68 MG. The contract has an ultimate completion date of January 14, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,429.38 firm fixed-price delivery order is for the supply of 68 mg Nexplanon contraceptive implants. It is part of a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which covers a wide range of pharmaceutical products to support the...
  • SPE2DB24D9241
    Indefinite Delivery Contract
  • SPE2DB24D9241-SPE2DB24FHGKS
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD), to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the contraceptive implant Nexplanon 68 mg, with a ceiling value of $2,144.07 and a period of performance through September 20, 2024. The contract is a firm fixed-price delivery order with no set-aside designation.

DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including both routine and specialized medications, to support the diverse medical needs of military personnel and their dependents across various DoD healthcare facilities.

Generated 11/28/24, 9:14 AM